If your chronic inflammatory demyelinating polyneuropathy (CIDP) treatment has hit a plateau, new options like FcRn ...

Olympian Michael Klim forged his reputation on strength and athleticism. But after being blindsided by an incurable ...

In a poignant journey of resilience, Olympian Michael Klim faced a life-altering challenge when his athletic prowess was stripped away by chronic inflammatory demyelinating polyneuropathy (CIDP). This ...

(BPT) – “At first I was kind of like, what is that? What is CIDP? I’ve never heard of that. But then, the relief set in more than confusion … because at least there was a name to what I had.” ...

WAYNE, Pennsylvania (WPVI) -- One step at a time, those who are diagnosed with rare neuropathic conditions such as GBS or CIDP prove it's possible to get back on their feet. A great place to see their ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Vyvgart Hytrulo in a once-weekly, 30- to 90-second subcutaneous injection to treat adults ...

In addition to working with your neurologist to establish a treatment plan, you can implement a few strategies into your daily or weekly routine to make every day life with CIDP a bit easier. Here are ...

Argenx SE (NASDAQ:ARGX) ranks among the best high growth European stocks to buy. On January 12, William Blair maintained its Outperform rating on Argenx SE (NASDAQ:ARGX), citing robust sales growth in ...

Klim's proposal to Owen came six years after they began dating, marking a significant milestone in their relationship. The couple's romance was first made public in October 2019, just five months ...

(RTTNews) - argenx SE (ARGX) said that the U.S. Food and Drug Administration has accepted for priority review a supplemental Biologics License Application or sBLA for VYVGART Hytrulo (efgartigimod ...

CEO Tim Van Hauwermeiren emphasized 2024 as a "phenomenal year," highlighted by expanding the reach of VYVGART to over 10,000 patients globally across three approved indications. He noted the ...